Cargando…

Integrative multi-omics analysis unveils stemness-associated molecular subtypes in prostate cancer and pan-cancer: prognostic and therapeutic significance

BACKGROUND: Prostate cancer (PCA) is the fifth leading cause of cancer-related deaths worldwide, with limited treatment options in the advanced stages. The immunosuppressive tumor microenvironment (TME) of PCA results in lower sensitivity to immunotherapy. Although molecular subtyping is expected to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Kun, Hai, Youlong, Xi, Yue, Zhang, Yukun, Liu, Zheqi, Chen, Wantao, Hu, Xiaoyong, Zou, Xin, Hao, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629187/ https://www.ncbi.nlm.nih.gov/pubmed/37936202 http://dx.doi.org/10.1186/s12967-023-04683-6

Ejemplares similares

Prognostic and Functional Significant of Heat Shock Proteins (HSPs) in Breast Cancer Unveiled by Multi-Omics Approaches
por: Buttacavoli, Miriam, et al.
Publicado: (2021)

Beyond the Gleason score: the prognostic significance of prostate cancer subtypes
por: Flood, Trevor A., et al.
Publicado: (2018)

Pan-cancer analysis from multi-omics data reveals AAMP as an unfavourable prognostic marker
por: Wang, Yang, et al.
Publicado: (2023)

Simultaneous Interrogation of Cancer Omics to Identify Subtypes With Significant Clinical Differences
por: Xu, Aodan, et al.
Publicado: (2019)

Identification of Pan-Cancer Prognostic Biomarkers Through Integration of Multi-Omics Data
por: Zhao, Ning, et al.
Publicado: (2020)

A pan-cancer analysis of the expression and prognostic significance of PDRG1
por: Liu, Zhen, et al.
Publicado: (2023)

Pan-cancer analysis of the prognostic significance and oncogenic role of GXYLT2
por: Song, Yi-Bei, et al.
Publicado: (2023)

Identification of Bladder Cancer Subtypes Based on Necroptosis-Related Genes, Construction of a Prognostic Model
por: Nie, Shiwen, et al.
Publicado: (2022)

Pan-cancer analyses reveal multi-omics and clinical characteristics of RIO kinase 2 in cancer
por: Li, Kexin, et al.
Publicado: (2022)

Omics- and Pharmacogenomic Evidence for the Prognostic, Regulatory, and Immune-Related Roles of PBK in a Pan-Cancer Cohort
por: Liu, Yi, et al.
Publicado: (2021)

Clinical significance of subtypes of Gleason pattern 4 prostate cancer
por: Hassan, Oudai, et al.
Publicado: (2018)

Pan-Cancer Pyroptosis Analyses Identified Novel Immunology and Chemotherapy-Related Prognostic Signatures in Cancer Subtypes
por: Li, Canrong, et al.
Publicado: (2022)

A hierarchical spike-and-slab model for pan-cancer survival using pan-omic data
por: Samorodnitsky, Sarah, et al.
Publicado: (2022)

Prognostic significance of the pretreatment pan-immune-inflammation value in cancer patients: an updated meta-analysis of 30 studies
por: Hai-Jing, Yu, et al.
Publicado: (2023)

Prostate cancer in omics era
por: Gholami, Nasrin, et al.
Publicado: (2022)

Identify the Prognostic and Immune Profile of VSIR in the Tumor Microenvironment: A Pan-Cancer Analysis
por: Liu, Yuanyuan, et al.
Publicado: (2022)

Therapeutic and prognostic potential of GPCRs in prostate cancer from multi-omics landscape
por: Li, Shiqi, et al.
Publicado: (2022)

Multi-omics analysis of expression and prognostic value of NSUN members in prostate cancer
por: Sun, Guangyu, et al.
Publicado: (2022)

A Multi-Omics Pan-Cancer Analysis of 4EBP1 in Cancer Prognosis and Cancer-Associated Fibroblasts Infiltration
por: Du, Kunpeng, et al.
Publicado: (2022)

Glutamine Metabolism Regulators Associated with Cancer Development and the Tumor Microenvironment: A Pan-Cancer Multi-Omics Analysis
por: Zou, Jingwen, et al.
Publicado: (2021)

Pan-cancer analysis of IFN-γ with possible immunotherapeutic significance: a verification of single-cell sequencing and bulk omics research
por: Wei, Xiaoying, et al.
Publicado: (2023)

Multi-omics analysis reveals interferon-stimulated gene OAS1 as a prognostic and immunological biomarker in pan-cancer
por: Yang, Runyu, et al.
Publicado: (2023)

Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types
por: Dai, Lirui, et al.
Publicado: (2023)

Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer Analysis
por: Liu, Peng, et al.
Publicado: (2022)

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
por: Lindskrog, Sia Viborg, et al.
Publicado: (2021)

Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data
por: Zhao, Hongying, et al.
Publicado: (2022)

Deep multi-omics integration by learning correlation-maximizing representation identifies prognostically stratified cancer subtypes
por: Ji, Yanrong, et al.
Publicado: (2023)

Unveiling the interplay between mutational signatures and tumor microenvironment: a pan-cancer analysis
por: Luo, Li-Zhi, et al.
Publicado: (2023)

Pan-cancer analysis identifies telomerase-associated signatures and cancer subtypes
por: Luo, Zhenhua, et al.
Publicado: (2019)

The Pan-Cancer Multi-Omics Landscape of FOXO Family Relevant to Clinical Outcome and Drug Resistance
por: Xie, Jindong, et al.
Publicado: (2022)

Risk subtyping and prognostic assessment of prostate cancer based on consensus genes
por: Meng, Jialin, et al.
Publicado: (2022)

Pan-urologic cancer genomic subtypes that transcend tissue of origin
por: Chen, Fengju, et al.
Publicado: (2017)

Multi-Omics Analysis Reveals the Pan-Cancer Landscape of Bone Morphogenetic Proteins
por: Luo, Wen-Li, et al.
Publicado: (2020)

Evidence of Omics, Immune Infiltration, and Pharmacogenomic for SENP1 in the Pan-Cancer Cohort
por: Taghvaei, Somayye, et al.
Publicado: (2021)

Evidence of Omics, Immune Infiltration, and Pharmacogenomics for BATF in a Pan-Cancer Cohort
por: Jia, Chenguang, et al.
Publicado: (2022)

Multi-Omics Analysis of MCM2 as a Promising Biomarker in Pan-Cancer
por: Yuan, Jing, et al.
Publicado: (2022)

An integrated multi-omics analysis of topoisomerase family in pan-cancer: Friend or foe?
por: Zhou, Xin, et al.
Publicado: (2022)

Multi-Omics Analysis and Verification of the Oncogenic Value of CCT8 in Pan-Cancers
por: Gong, Lian, et al.
Publicado: (2023)

Pan-cancer analysis reveals the prognostic and immunologic roles of cereblon and its significance for PROTAC design
por: Zhang, Si-Han, et al.
Publicado: (2023)

Comprehensive pan-cancer analysis of expression profiles and prognostic significance for NUMB and NUMBL in human tumors
por: Zhang, Yue, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8n570ehtgdlaupfut5j0g2noct